CD19-Positive Neoplastic Cells Present

Clinical trial pipeline · Data from ClinicalTrials.gov

See which CD19-Positive Neoplastic Cells Present trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 1/2

NCT01865617

Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Ly…

This phase I/II trial studies the side effects and best dose of laboratory treated T cells to see how well they work in treating patients with chronic lymphocyt…

United States204 participantsStarted 2013-05-22

Treatment: Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing T Lymphocytes